(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/12/13 | 日証協 | 159,094株 | +10.48% | 81,600株 | +24.77% | 152,166株 | +7.95% | 37,300株 | +49.2% |
2019/12/06 | 日証協 | 144,000株 | +2.2% | 65,400株 | +29.25% | 140,966株 | -2.22% | 25,000株 | -33.69% |
2019/11/29 | 日証協 | 140,900株 | -8.86% | 50,600株 | -37.3% | 144,166株 | +4.19% | 37,700株 | +84.8% |
2019/11/22 | 日証協 | 154,600株 | -36.19% | 80,700株 | +1% | 138,366株 | -24.87% | 20,400株 | +22.16% |
2019/11/15 | 日証協 | 242,300株 | -3.2% | 79,900株 | -4.54% | 184,176株 | -5.97% | 16,700株 | +68.69% |
2019/11/08 | 日証協 | 250,300株 | -5.51% | 83,700株 | -19.29% | 195,876株 | -6.18% | 9,900株 | -48.97% |
2019/11/01 | 日証協 | 264,900株 | -5.83% | 103,700株 | +228.16% | 208,776株 | -4.66% | 19,400株 | +165.75% |
2019/10/25 | 日証協 | 281,300株 | -14.73% | 31,600株 | -57.64% | 218,976株 | -16.41% | 7,300株 | -34.23% |
2019/10/18 | 日証協 | 329,900株 | -4.74% | 74,600株 | +8.75% | 261,976株 | -1.21% | 11,100株 | +226.47% |
2019/10/11 | 日証協 | 346,300株 | -6.76% | 68,600株 | +218.73% | 265,176株 | -7.76% | 3,400株 | -41.47% |
2019/10/04 | 日証協 | 371,400株 | -11.65% | 21,523株 | -73.19% | 287,482株 | -7.91% | 5,809株 | -56.92% |
2019/09/27 | 日証協 | 420,364株 | +4% | 80,280株 | +153.63% | 312,165株 | +4.1% | 13,484株 | +140.79% |
2019/09/20 | 日証協 | 404,186株 | -0.69% | 31,652株 | -10.59% | 299,876株 | -0.86% | 5,600株 | -76.76% |
2019/09/13 | 日証協 | 406,986株 | -3.85% | 35,400株 | -38.32% | 302,476株 | -1.95% | 24,094株 | +381.88% |
2019/09/06 | 日証協 | 423,285株 | +0.56% | 57,392株 | -44.72% | 308,476株 | -0.19% | 5,000株 | -15.25% |
2019/08/30 | 日証協 | 420,907株 | +0.27% | 103,812株 | +96.93% | 309,076株 | -0.23% | 5,900株 | -45.37% |
2019/08/23 | 日証協 | 419,784株 | -1.26% | 52,716株 | +5.54% | 309,776株 | -0.77% | 10,800株 | -25.52% |
2019/08/16 | 日証協 | 425,149株 | -0.61% | 49,949株 | -1.65% | 312,176株 | -3.25% | 14,500株 | +62.92% |
2019/08/09 | 日証協 | 427,749株 | -1% | 50,787株 | +25.09% | 322,676株 | -2.15% | 8,900株 | -54.36% |
※株式分割は考慮していませんのでご注意ください。
Page Top